Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000951869 | SCV000514010 | likely benign | not provided | 2020-10-20 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23552953) |
Ambry Genetics | RCV002314155 | SCV000847942 | benign | Inborn genetic diseases | 2017-11-13 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000438005 | SCV000863011 | likely benign | not specified | 2018-08-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000951869 | SCV001098315 | benign | not provided | 2024-11-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000951869 | SCV001150339 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | OPHN1: PM5, BS2 |
Fulgent Genetics, |
RCV002502479 | SCV002812416 | likely benign | X-linked intellectual disability-cerebellar hypoplasia syndrome | 2021-09-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000951869 | SCV005210572 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000951869 | SCV001800168 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000951869 | SCV001932702 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000951869 | SCV001967503 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004530541 | SCV004752061 | likely benign | OPHN1-related disorder | 2021-07-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |